T6	Effect 51 73	hematologic malignancy
T8	Treatment 155 194	etoglucid, doxorubicin, and mitomycin C
T9	Subject 0 34	Two cases are reported of patients
T10	Treat-Disorder 123 149	superficial bladder cancer
T11	Treatment 74 194	several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and mitomycin C
T7	Route 94 119	intravesical chemotherapy
T12	Drug 155 164	etoglucid
T13	Drug 166 177	doxorubicin
T14	Drug 183 194	mitomycin C
T16	Population 0 3	Two
